@article{TLCR16898,
author = {Marius Ilie and Paul Hofman},
title = {Reproducibility of PD-L1 assessment in non-small cell lung cancer—know your limits but never stop trying to exceed them},
journal = {Translational Lung Cancer Research},
volume = {6},
number = {Suppl 1},
year = {2017},
keywords = {},
abstract = {Immunotherapy targeting the programmed death 1 (PD-1)/ programmed death-ligand 1 (PD-L1) pathway has demonstrated strong and durable anti-tumoral immune responses with significantly improved overall survival in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) (1).},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/16898}
}